Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
GLOBETECH MEDIA

Diabetes Drug Decreases Psychostimulant Addiction Behavior

By BiotechDaily International staff writers
Posted on 06 Nov 2012
Researchers report a drug currently used for the medical management of type 2 diabetes could also be effective for treating addiction to often-abused psychostimulants.

Researchers from Vanderbilt University (Nashville, TN, USA) have found that a brain mechanism known to be a therapeutic target in treating type 2 diabetes mellitus also appears to be involved in some forms of drug addiction. In a study of cocaine addiction, animals were injected with the diabetes drug Exendin-4, a longer-lasting analog of the natural hormone glucagon-like peptide-1 (GLP-1), which is released in response to nutrient ingestion and is a regulator of energy metabolism and feeding behavior. The resulting behavior showed significant reduction of the rewarding effects of cocaine and the findings were consistent over a broad range of Exendin-4 dosage. The study reported no evidence of negative side effects or addiction to Exendin-4 treatment.

“We suspect that this is a general mechanism that will translate to additional drugs of abuse, especially other stimulants, like amphetamine and methamphetamine,” said Gregg Stanwood, PhD, assistant professor of Pharmacology and an investigator in the Vanderbilt Kennedy Center and Vanderbilt Brain Institute. "I think the power of this research is that it is so easily translatable to humans because [Extendin-4] is already FDA approved [for diabetes]," said Aurelio Galli, PhD, professor of Molecular Physiology and Biophysics, Vanderbilt Brain Institute investigator, and codirector of the Neuroscience Program in Substance Abuse. "Any disease that is based on dysregulated dopamine can be potentially targeted. There is a lot of comorbidity between metabolic disorders like diabetes and obesity and psychiatric disease like addiction and schizophrenia."

Prof. Stanwood noted that although it is important to be very cautious in extrapolating the results to humans, these are encouraging data. “There are no medically based therapies for stimulant addiction that have been successful in the clinic, although there are a variety of psychosocial and behavioral therapies that are somewhat effective in some people,” said Prof. Stanwood. “The beauty of this is that it targets a completely new mechanism so we are cautiously hopeful [...]. We don’t expect this to be a magic bullet where one can simply take this drug and their addiction goes away, but hopefully a medicine like this, in combination with social and behavioral support, will help an addict on the road to recovery.”

The findings were published early online October 23, 2012, in the journal Molecular Psychiatry.

Related Links:

Vanderbilt University



Channels

Genomics/Proteomics

view channel
Image: An adult cardiomyocyte has re-entered the cell cycle after expression of miR302-367 (Photo courtesy of the laboratory of Dr. Edward Morrisey, University of Pennsylvania).

Certain MicroRNAs Stimulate Regeneration of Adult Heart Tissue

Cardiac disease researchers working with a mouse model have discovered that by inducing a subset of microRNAs (miRNAs) that are active during development but silenced in the adult they could cause damaged... Read more

Biochemistry

view channel
Image:  Model depiction of a novel cellular mechanism by which regulation of cryptochromes Cry1 and Cry2 enables coordination of a protective transcriptional response to DNA damage caused by genotoxic stress (Photo courtesy of the journal eLife, March 2015, Papp SJ, Huber AL, et al.).

Two Proteins Critical for Circadian Cycles Protect Cells from Mutations

Scientists have discovered that two proteins critical for maintaining healthy day-night cycles also have an unexpected role in DNA repair and protecting cells against genetic mutations that could lead... Read more

Business

view channel

“Softer” Mass Spec Techniques Gain Advantage in Biomarker Discovery

Two mass spectrometry (MS) technologies, MALDI and DESI, are increasing in applications as their effectiveness is established, according to Kalorama Information (New York, NY, USA) in its report “Proteomics Markets for Research and IVD Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays,... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.